A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,153

Participants

Timeline

Start Date

October 6, 2023

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2026

Conditions
Respiratory Syncytial Virus
Interventions
BIOLOGICAL

mRNA-1345

Sterile liquid for injection

Trial Locations (44)

23435

Velocity Clinical Research - Family Practice - Suffolk - PPDS, Suffolk

27710

Duke University Medical Center, Durham

33434

Excel Medical Clinical Trials DBA Flourish, Boca Raton

68510

Velocity Clinical Research (Lincoln - Nebraska) - PPDS, Lincoln

70433

Benchmark Research - Covington - HyperCore - PPDS, Covington

72205

Baptist Health Center for Clinical Research, Little Rock

80228

Critical Care, Pulmonary and Sleep Associates / CCT Research, Lakewood

84663

Springville Dermatology - CCT - PPDS, Springville

85308-5093

Lenzmeier Family Medicine - CCT - PPDS, Glendale

85044-6097

Foothills Research Center - CCT - PPDS, Phoenix

85283-1528

Fiel Family & Sports Medicine - PC - CCT - PPDS, Tempe

90095-3075

David Geffen School of Medicine at UCLA, Los Angeles

92103-2209

Artemis Institute For Clinical Research LLC - San Diego - Headlands - PPDS, San Diego

06510-2483

Yale University School of Medicine, New Haven

33012-4170

Indago Research and Health Center, Hialeah

33024-2709

CenExel RCA - Hollywood, Hollywood

30281-9054

Clinical Research Atlanta - Headlands - PPDS, Stockbridge

83404-7573

Snake River Research, PLLC, Idaho Falls

60637-1443

University of Chicago, Chicago

61614-4885

AES - DRS - Optimal Research Illinois - Peoria, Peoria

20854-2960

Velocity Clinical Research (Rockville - Maryland) - PPDS, Rockville

48202-2608

Henry Ford Hospital, Detroit

48076-5412

DM Clinical Research - Southfield - ERN - PPDS, Southfield

14621-3011

University of Rochester - Rochester General Hospital - PPDS, Rochester

10467-2401

Montefiore Medical Center - BRANY - PPDS, The Bronx

19107-1530

DM Clinical Research - Philadelphia - ERN - PPDS, Philadelphia

76135-5283

Benchmark Research - Fort Worth - HyperCore - PPDS, Fort Worth

77065-5685

DM Clinical Research - Cyfair Clinical Research Center, Houston

76904-7610

Benchmark Research - San Angelo - HyperCore - PPDS, San Angelo

77375-6543

DM Clinical Research - ERN - PPDS, Tomball

23666-6262

Velocity Clinical Research - Hampton - PPDS, Hampton

23435-3763

Centricity Research Suffolk Family Medicine, Suffolk

T6G 2B7

University of Alberta, Edmonton

V1Y 1Z9

OCT Research ULC (dba Okanagan Clinical Trials), Kelowna

L7 8XZ

Canadian Center for Vaccinology, Halifax

Liverpool School of Tropical Medicine, Liverpool

B2N 1L2

Colchester Research Group, Truro

J1L 0H8

Diex Recherche - Sherbrooke - PPDS, Sherbrooke

G1V 4T3

Diex Recherche - Québec - PPDS, Québec

00918

Caribbean Medical Research Center, San Juan

EX2 5DW

Royal Devon and Exeter Hospital, Exeter

FY3 7EN

Fylde Coast Clinical Research, Blackpool

AB25 2ZD

Aberdeen Royal Infirmary - PPDS, Aberdeen

NW3 2QG

The Royal Free Hospital, London

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY

NCT06067230 - A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults | Biotech Hunter | Biotech Hunter